http://doi.org/10.31288/oftalmolzh2010195101

DEEP SCLERECTOMY IN EXFOLIATIVE GLAUCOMA AND PRIMARY OPEN-ANGLE GLAUCOMA.

Tharwat H. Mokbel, MD, Asaad A. Ghanem, MD, Ashraf I. Moawad, MD, Ihab M. NafieMD.

Departments of Ophthalmolgy, Faculty of Medicine, Mansoura University, Egypt.

Purpose: To compare the surgical outcomes of non-penetrating deep sclerectomy in Exfoliative Glaucoma (ExG) and Primary Open-angle Glaucoma (POAG)patients.

Patients and Methods: Deep sclerectomy performed in 20 eyes with ExG and 25 eyes with POAG. Postoperative intraocular pressure (IOP), number of glaucoma medications, visual acuity, surgical success rate and complications were assessed for 12 months. Complete success was defined by the achievement of postoperative IOP < 21 mmHg without medication.

Results: The mean postoperative IOP was significantly lower (P < 0. 05) in ExG and POAG eyes than preoperative. The mean IOP was 17. 6 + 3. 5 mmHg in ExG eyes and 16. 1 + 4. 6 mmHg in POAG eyes. At 12 months, complete success had been achieved in 45% of ExG eyes and 40% of POAG eyes. Qualified success had been achieved in 45% of ExG eyes and 52% of POAG eyes. No statistically significant differences in visual acuity, number of postoperative glaucoma medications, visual field changes and number of complications were found in ExG eyes and POAG eyes.

Conclusions: Deep sclerectomy is effective in controlling IOP, lowers the need for postoperative medications, and lowers the rates of serious complications in both ExG and POAG eyes.

 

REFERENCES

1.Krasnov MM. Microsurgery of glaucoma. Indications and choice of technique. Am J Ophthalmol 1969;67:857-864.

2.Stegmann R,Pienaar A,Miller D. Viscocanalostomy for open-angle glaucoma in black-African patients. J Cataract Refract Surg 1999;25:316-322.

3.El-sayyad F,Helal M,El-Kholify H, et al. Nonpenetrating

deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology 2000;107:1671-1674.

4.Mermoud A. Sinusotomy and deep sclerectomy. Eye 2000;14:531-535.

5.Krause U, Alanko I, Kama J, et al. Prevalance of exfoliative syndrome in Finland. Acta Ophthalmol 1988;184:120- 122.

6.Citirik M,Acaroglu G,Batman C,et al. A positive link between the pseudoexfoliation syndrome and coronary artery disease. Eye 2007;21:11-15.

7.Parodi MB,Liberali T,Lacono P,et al. The spectrum of iris angiography abnormalities in pseudoexfoliation syndrome. Eye 2008;22:49-54.

8.Konstas  AGP,Jay  JL,   Marshall  GE,and  Lee WR. Prevalance,diagnostic features and response to trabeculectomy in exfoliation glaucoma. Ophthalmology 1993;100:619-627.

9.Shaarawy T,Karlen ME,Schnyder CC, et al. Five year re-sults of deep sclerectomy with collagen implant. J Catract Refract Surg 2001;27:1770-1778.

10.Picht G,and Grehn E. Classification of filtering blebs in tra-beculectomy:biomicroscopy and functionality. Curr Opin Ophthalmol 1998;9:2-8.

11.Aasved H,Seland JH,and Slagsvold JE. Timolol meleate in treatment of open-angle glaucoma. Acta Ophthalmol 1979;57:700-708.

12.Jampel HD,Musch DC,Gillespie BW,et al. Perioperative complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol 2005;140:16-22.

13.Vaudaux JUSMA. Aqueous dynamics after deep sclerectomy:in vitro study. Ophthalmic Practice 1999;16:204-209.

14.Hamarad P,Valtot F,Sourdille P,Bourles-Dagonet F,and BaudouinC. Confocal microscopic examination of trabecular meshwork removed during abexterno trabeculectomy. Br J Ophthalmol 2002;86:1046-1052.

15.Shaarawy T,and Mermoud A. Deep sclerectomy in one eye VS deep sclerectomy with collagen implant in the contralateral eye of the same patient:long-term follow-up. Eye 2005;19:298-302.

16.Abdelrahman AM. Trabeculotome-guided sclerectomy. Apiolt study. Am J Ophthalmol 2005;140:152-154.

17.Rekonen P,Kannisto T,Puustjarvi T,et al. Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma. Acta Ophthalmol Scand 2006;84:507-511.

18.Drolsum L. Conversion from trabeculectomy to deep scle-rectomy. Prospective study of the first 44 cases. J Catract Refract Surg 2003;29:1378-1384.

19.Lachkar Y,Neverauskiene J,Jeanteur-lunel MN, et al. Nonpenetrating deep sclerectomy;a 6-year retrospective study. Eur J Ophthalmol 2004;214:26-36.

20.Klink T,Schlunk G,Lieb WE,Klink J, et al. Long-term re-sults of Erbium YAG-laser assisted deep sclerectomy. Eye

2008;22:370-374.

21.Wishart PK, Wishart MS, and Porooshani H. Viscocanalos-tomy and deep sclerectomy for the surgical treatment of glaucoma: a long term follow up. Acta Ophthalmol Scand 2003; 81: 343-348.

22.Drolsum L. Long-term follow-up after deep sclerectomy in patients with pseudoexfoliative glaucoma. Acta Ophthal¬mol Scand 2006;84:502-506.

 

23.Rebolleda G and Munoz-Negrete FJ. Deep sclerectomy with mitomycin C in failed trabeculectomy. Eye 2007;21:23-28.